DNA Methylation and Histone Modification in Hypertension
AbstractSystemic hypertension, which eventually results in heart failure, renal failure or stroke, is a common chronic human disorder that particularly affects elders. Although many signaling pathways involved in the development of hypertension have been reported over the past decades, which has led to the implementation of a wide variety of anti-hypertensive therapies, one half of all hypertensive patients still do not have their blood pressure controlled. The frontier in understanding the molecular mechanisms underlying hypertension has now advanced to the level of epigenomics. Particularly, increasing evidence is emerging that DNA methylation and histone modifications play an important role in gene regulation and are involved in alteration of the phenotype and function of vascular cells in response to environmental stresses. This review seeks to highlight the recent advances in our knowledge of the epigenetic regulations and mechanisms of hypertension, focusing on the role of DNA methylation and histone modification in the vascular wall. A better understanding of the epigenomic regulation in the hypertensive vessel may lead to the identification of novel target molecules that, in turn, may lead to novel drug discoveries for the treatment of hypertension. View Full-Text
Share & Cite This Article
Stoll, S.; Wang, C.; Qiu, H. DNA Methylation and Histone Modification in Hypertension. Int. J. Mol. Sci. 2018, 19, 1174.
Stoll S, Wang C, Qiu H. DNA Methylation and Histone Modification in Hypertension. International Journal of Molecular Sciences. 2018; 19(4):1174.Chicago/Turabian Style
Stoll, Shaunrick; Wang, Charles; Qiu, Hongyu. 2018. "DNA Methylation and Histone Modification in Hypertension." Int. J. Mol. Sci. 19, no. 4: 1174.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.